TRULIEVE CANNABIS CORP
TRLVNYSE🏆 #1983 by market capEarnings Nov 5 · PreUS Equity
$10.58▼ $0.07 (−0.66%)
Market closed · at closeTrack TRLV
Get earnings, price moves & breaking news on Telegram
24h▼ 0.7%
7d▲ 1.6%
14d▲ 5.7%
30d▼ 3.0%
ytd—
1y—
🏦Market Cap
$1.80B
Small Cap
📈Revenue Growth (YoY)
0.0%
Slowing
📊Gross Margin
59.5%
Healthy
💵FCF Margin
16.4%
Healthy
⚖️P/S Ratio
1.6x
Cheap
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $10.40 – $10.86
- 52-Week Range
- $4.62 – $13.28
- Volume (shares)
- 76,049
- Avg Volume (shares)
- —
- Shares Outstanding
- 170.2M
- Next Earnings
- 2026-11-05
Fundamentals Snapshot
- Annual Revenue
- $1.18B
- Last Q Revenue
- $271M
- P/E Ratio
- -4.3
- P/S Ratio
- 1.6x
- EPS (TTM)
- $-2.46
- Dividend Yield
- 0.00%
TRULIEVE CANNABIS CORP
TRLVFinancial Trends
Financial history unavailable.
StockOtter · stockotter.spaceAbout TRULIEVE CANNABIS CORP
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Insufficient data
—/100
Analyst Ratings
ⓘConsensus
Buy
13 analysts
Strong Buy2
Buy10
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.